Demonstrações financeiras detalhadas de CAMP4 Therapeutics Corporation (CAMP): demonstração de resultados, balanço patrimonial e fluxo de caixa. Acompanhe a evolução de margens, dívida, liquidez e rentabilidade ano a ano com até 20 anos de histórico.
Resumo da Análise
CAMP4 Therapeutics Corporation registou receitas de $3.5M no último exercício, com um CAGR de 5 anos de -59.2%.
Margens dos últimos 12 meses: margem bruta 77.8%, margem operacional -12.4%, margem líquida -25.4%.
Ao preço atual de $3.86, CAMP apresenta lucros negativos (P/L não significativo) e um ROE de -314.08%. A capitalização de mercado é de $82M.
Demonstração de Resultados (10 anos)
| Ano | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Receita | $351.1M | $365.9M | $363.8M | $366.1M | $308.6M | $295.8M | $294.9M | $350000 | $652000 | $3.5M |
| Custo da Receita | $207.8M | $215.0M | $216.0M | $222.8M | $186.2M | $174.0M | $185.9M | 0 | 0 | $1.6M |
| Lucro Bruto | $143.4M | $150.9M | $147.8M | $143.3M | $122.4M | $121.9M | $109.0M | $350000 | $652000 | $1.9M |
| P&D | $22.0M | $25.8M | $27.7M | $29.4M | $25.8M | $28.4M | $24.6M | $40.6M | $38.8M | $38.2M |
| Despesas Gerais e Administrativas | $104.9M | $102.2M | $81.0M | $118.2M | $95.3M | $100.9M | $99.2M | $11.6M | $14.9M | $17.4M |
| Despesas Operacionais | $142.0M | $142.9M | $120.1M | $160.0M | $125.9M | $134.8M | $133.7M | $52.2M | $53.7M | $53.9M |
| Lucro Operacional | $1.3M | $8.0M | $19.7M | -$16.8M | -$6.8M | -$13.5M | -$24.7M | -$51.9M | -$53.1M | -$52.1M |
| EBITDA | $24.7M | $31.4M | $47.1M | $15.2M | $8.5M | -$2.6M | -$25.1M | -$50.2M | -$51.4M | -$50.4M |
| Despesas com Juros | $9.9M | $10.3M | $16.7M | $20.1M | $5.8M | $5.2M | $6.3M | 0 | 0 | 0 |
| Lucro Antes de Impostos | -$7.0M | $28.7M | $23.9M | -$58.3M | -$20.6M | -$30.1M | -$31.3M | -$49.3M | -$51.8M | -$80.4M |
| Imposto | -$1.1M | $10.7M | -$1.3M | $20.5M | $561000 | $1.1M | $1.2M | 0 | 0 | 0 |
| Lucro Líquido | -$7.2M | $16.6M | $18.4M | -$78.8M | -$56.3M | -$28.0M | -$32.5M | -$49.3M | -$51.8M | -$80.4M |
| LPA | $-0.20 | $0.47 | $0.53 | $-2.35 | $0.00 | $0.00 | $-0.90 | $-4.07 | $-2.66 | $-2.65 |
| LPA Diluído | $-0.20 | $0.46 | $0.52 | $-2.34 | $0.00 | $0.00 | $-0.90 | $-4.07 | $-2.66 | $-2.65 |
| Ações em Circulação (Diluídas) | $35.9M | $36.1M | $35.3M | $33.7M | $1.5M | $1.5M | $36.1M | $12.1M | $19.5M | $30.4M |
Balanço (10 anos)
| Ano | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Caixa e Equivalentes | $93.7M | $132.6M | $256.5M | $107.4M | $91.7M | $91.1M | $83.2M | $38.4M | $64.0M | $109.5M |
| Investimentos de Curto Prazo | $6.7M | $23.4M | $17.5M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Contas a Receber | $67.4M | $71.6M | $78.1M | $72.3M | $67.9M | $58.6M | $678000 | $442000 | $108000 | $155000 |
| Estoque | $29.3M | $36.3M | $32.0M | $36.8M | $32.2M | $20.2M | 0 | 0 | 0 | 0 |
| Ativos Circulantes | $206.7M | $275.9M | $403.5M | $237.9M | $215.2M | $193.6M | $84.4M | $40.0M | $66.4M | $114.1M |
| Imobilizado | $21.2M | $21.3M | $27.0M | $76.5M | $62.2M | $50.1M | $16.8M | $13.3M | $10.3M | $2.7M |
| Ágio | $73.0M | $73.0M | $80.8M | $106.3M | $94.5M | $94.0M | 0 | 0 | 0 | 0 |
| Ativos Intangíveis | $67.2M | $52.5M | $47.2M | $45.9M | $38.9M | $33.0M | 0 | 0 | 0 | 0 |
| Ativos Totais | $407.7M | $473.0M | $603.6M | $495.8M | $441.8M | $402.3M | $102.5M | $54.9M | $78.3M | $117.8M |
| Contas a Pagar | $30.3M | $35.5M | $39.9M | $28.4M | $36.8M | $30.8M | $2.2M | $1.0M | $1.2M | $182000 |
| Dívida de Curto Prazo | $11.0M | $32.2M | $36.8M | $37.8M | $10.9M | $7.7M | 0 | 0 | 0 | $286000 |
| Passivos Circulantes | $76.6M | $95.5M | $83.6M | $121.5M | $107.4M | $94.9M | $7.9M | $7.8M | $9.6M | $15.5M |
| Dívida de Longo Prazo | $146.8M | $154.3M | $275.9M | $201.4M | $199.9M | $201.4M | 0 | 0 | 0 | $1.7M |
| Passivos Totais | $243.7M | $274.1M | $398.0M | $357.9M | $342.5M | $322.1M | $180.1M | $178.7M | $15.2M | $70.1M |
| Reservas | -$47.0M | -$19.5M | -$2.2M | -$81.5M | -$129.2M | -$156.8M | -$110.7M | -$160.0M | -$211.8M | -$292.2M |
| Patrimônio Líquido | $164.0M | $198.9M | $205.7M | $137.9M | $99.3M | $80.2M | -$77.5M | -$123.7M | $63.1M | $47.7M |
| Dívida Total | $146.8M | $154.3M | $275.9M | $234.5M | $210.8M | $209.2M | $12.4M | $11.7M | $8.6M | $2.0M |
| Dívida Líquida | $46.4M | -$1.7M | $1.9M | $127.1M | $119.1M | $118.1M | -$70.8M | -$26.7M | -$55.4M | -$107.5M |
| Capital de Giro | $130.1M | $180.4M | $319.9M | $116.4M | $107.8M | $98.7M | $76.5M | $32.2M | $56.8M | $98.6M |
Fluxo de Caixa (10 anos)
| Ano | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Lucro Líquido | -$7.9M | $16.6M | $18.4M | -$79.3M | -$56.3M | -$28.0M | -$44.2M | -$49.3M | -$51.8M | -$80.4M |
| Depreciação e Amortização | $23.5M | $23.0M | $9.8M | $23.3M | $22.0M | $22.8M | $878000 | $1.7M | $1.7M | $1.6M |
| Compensação em Ações | $7.8M | $9.3M | $9.5M | $10.7M | $11.4M | $11.3M | $1.4M | $2.9M | $4.0M | $4.0M |
| Variação Capital de Giro | -$2.0M | -$9.8M | -$24.7M | $3.7M | $11.0M | $1.6M | $373000 | -$154000 | -$1.9M | $13.0M |
| Fluxo de Caixa Operacional | $25.8M | $66.9M | $47.7M | $11.5M | $28.6M | -$4.2M | -$38.5M | -$44.2M | -$45.6M | -$29.6M |
| CapEx | -$8.0M | -$8.3M | -$10.4M | -$21.3M | -$11.4M | -$13.3M | -$4.0M | -$678000 | -$441000 | -$279000 |
| Aquisições | -$117.0M | 0 | -$13.0M | -$60.7M | 0 | 0 | 0 | 0 | 0 | $36000 |
| Recompra de Ações | -$25.0M | 0 | -$49.0M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividendos Pagos | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Fluxo de Caixa Livre | $17.8M | $58.6M | $37.3M | -$9.8M | $17.2M | -$17.5M | -$42.6M | -$44.8M | -$46.0M | -$29.8M |
Crescimento e Margens (10 anos)
| Ano | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Crescimento Receita (anual) | +4.2% | -0.6% | +0.6% | -15.7% | -4.1% | -0.3% | -99.9% | +86.3% | +436.5% | |
| Crescimento Lucro Líquido (anual) | +332.4% | +10.7% | -528.2% | +28.5% | +50.3% | -16.1% | -51.7% | -5.1% | -55.2% | |
| Crescimento LPA (anual) | +335.0% | +12.8% | -543.4% | +100.0% | -352.2% | +34.6% | +0.4% | |||
| Variação de Ações (anual) | +0.6% | -2.3% | -4.6% | -95.6% | +2.5% | +2257.3% | -66.4% | +60.9% | +55.8% | |
| Crescimento FCF (anual) | +228.3% | -36.2% | -126.1% | +276.6% | -201.7% | -143.0% | -5.3% | -2.6% | +35.2% | |
| Margem Bruta | 40.8% | 41.2% | 40.6% | 39.1% | 39.7% | 41.2% | 37.0% | 100.0% | 100.0% | 53.1% |
| Margem Operacional | 0.4% | 2.2% | 5.4% | -4.6% | -2.2% | -4.6% | -8.4% | -14822.6% | -8142.3% | -1488.3% |
| Margem EBITDA | 7.0% | 8.6% | 12.9% | 4.2% | 2.7% | -0.9% | -8.5% | -14343.1% | -7882.2% | -1441.5% |
| Margem Líquida | -2.0% | 4.5% | 5.1% | -21.5% | -18.2% | -9.5% | -11.0% | -14083.1% | -7943.4% | -2298.5% |
| Margem FCF | 5.1% | 16.0% | 10.3% | -2.7% | 5.6% | -5.9% | -14.4% | -12809.4% | -7055.7% | -852.8% |
| Taxa Efetiva de Imposto | 15.8% | 37.2% | -5.6% | -35.1% | -2.7% | -3.6% | -3.7% | -0.0% | -0.0% | -0.0% |
Dados por Ação (10 anos)
| Ano | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| FCF por Ação | $0.50 | $1.62 | $1.06 | $-0.29 | $11.52 | $-11.43 | $-1.18 | $-3.70 | $-2.36 | $-0.98 |
| Dividendo por Ação | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Ações em Circulação (Básicas) | $35.9M | $35.2M | $34.6M | $33.5M | $1.5M | $1.5M | $36.1M | $12.1M | $19.5M | $30.4M |
O que olhar em Biotech
A maioria das biotechs pequenas perde dinheiro. Analisar com P/E não faz sentido — olha caixa e pipeline.
- Cash Runway — Meses de caixa ao ritmo atual de gasto. <18 meses = risco de diluição urgente
- Cash burn anual — Ritmo a que queimam caixa operacional. Comparar com posição de caixa para projetar runway
- Dívida Total — Biotech sem receita + dívida = receita para falência
- I+D / Capitalização — Quanto investem em pipeline vs valor da empresa — indicador de intensidade de pesquisa
- Market cap / Caixa — Se cota perto do caixa, o mercado dá ~0 valor ao pipeline — oportunidade ou armadilha
Rentabilidade
| Retorno sobre patrimônio | -314.08% |
| Retorno sobre capital investido | -69.76% |
| Retorno sobre ativos | -114.79% |
| Margem bruta | 77.80% |
| Margem operacional | -1242.50% |
| Margem líquida | -2543.74% |
Saúde financeira
| Dívida / Patrimônio | -3.42 |
| Liquidez corrente | 4.70 |
Índices Chave (10 anos)
| Ano | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| P/L | -53.60 | 22.81 | 20.23 | -4.56 | -0.28 | -0.59 | -11.91 | -2.63 | -1.96 | -2.31 |
| P/VP | 2.35 | 1.90 | 1.80 | 2.60 | 0.16 | 0.20 | -5.00 | -1.05 | 1.61 | 3.90 |
| P/V | 1.10 | 1.03 | 1.02 | 0.98 | 0.05 | 0.06 | 1.31 | 371.36 | 156.16 | 53.24 |
| Margem Bruta | 40.8% | 41.2% | 40.6% | 39.1% | 39.7% | 41.2% | 37.0% | 100.0% | 100.0% | 53.1% |
| Margem Operacional | 0.4% | 2.2% | 5.4% | -4.6% | -2.2% | -4.6% | -8.4% | -14822.6% | -8142.3% | -1488.3% |
| Margem Líquida | -2.0% | 4.5% | 5.1% | -21.5% | -18.2% | -9.5% | -11.0% | -14083.1% | -7943.4% | -2298.5% |
Empresas relacionadas: ACRV · ALXO · ATYR · BMEA · HYFT · PMVP · QNCX
Explorar setor: Healthcare · Biotechnology
Mais seções de CAMP: Resumo · Avaliação · Estatísticas · Estimativas · Técnico · Propriedade · Notícias · Eventos
Descubra mais: Radar — sinais de ações subvalorizadas · Academia de Investimento — aprenda a analisar ações